Table 4.
Procedure | Radiotracer | Effective dose per MBq | Recommended activity | Resulting effective dose | References |
---|---|---|---|---|---|
ERNA | [99mTc]Tc-RBCs | 0.0047 mSv/MBq | 555–1110 MBq | 2.6–5.2 mSv | [24] |
SPECT MPI | [99mTc]Tc-labeled perfusion tracers |
[99mTc]Tc-tetrofosmin (stress and rest): 0.0058 and 0.0063 mSv/MBq, respectively [99mTc]Tc-sestamibi (stress and rest): 0.0066 and 0.0070 mSv/MBq, respectively |
Depending on protocol (1-day vs. 2-day protocol, stress only, CZT vs. conventional camera etc.): 150–400 MBq (stress), 180–1200 MBq (rest) | 0.9–11.2 mSv | [29, 111] |
PET MPI | [15O]H2O | 0.0011 mSv/MBq | 2 × 400 MBq (stress/rest) | 0.8 mSv | [36, 112] |
82Rb | 0.001 mSv/MBq | 2 × 10 MBq/kg (stress/rest) | 1.5 mSv | [36, 112, 113] | |
[13N]NH3 | 0.0027 mSv/MBq | 2 × 400 MBq (stress/rest) | 1.8 mSv | [36, 112, 113] | |
Innervation SPECT | [123I]mIBG | 0.037 mSv/MBq | 111–370 MBq | 4.1 – 13.7 mSv | [114] |
Viability/inflammation PET | 2-[18F]FDG | 0.019 mSv/MBq | 185–555 MBq | 3.5–10.5 mSv | [112, 115, 116] |
Vascular toxicity PET | 2-[18F]FDG | 0.019 mSv/MBq | 3–4 MBq/kg | 4–7.5 mSv | [94, 112] |
[99mTc]Tc-RBCs, [99mTc]Tc-labeled red blood cells; [123I]mIBG, [123I]-metaiodobenzylguanidine; [18F]FDG, 2-[18F]fluoro-2-deoxy-D-glucose; ERNA, equilibrium radionuclide angiography; MPI, myocardial perfusion imaging; PET, positron emission tomography; SPECT, single-photon emission computed tomography